Best Peptides for Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder characterized by recurring abdominal pain, bloating, and altered bowel habits without identifiable structural damage. Research into peptides like BPC-157 focuses on their potential to modulate gut barrier function, reduce inflammation, and normalize intestinal motility through mechanisms including growth factor upregulation and nitric oxide system enhancement. Current research explores how peptides may address underlying pathophysiology rather than simply managing symptoms.

IBS research protocols typically employ lower systemic doses compared to musculoskeletal applications, often administered subcutaneously or orally in divided doses to maintain consistent GI exposure. Dosing frequency and duration vary considerably across research models, with some studies examining daily administration over 4-12 week periods, though optimal timing relative to meals and individual response variability remain active areas of investigation.